Exane Derivatives’s Herc Holdings HRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$108K Sell
1,197
-810
-40% -$97.3K 0.06% 256
2022
Q1
$335K Sell
2,007
-1,344
-40% -$212K 0.09% 236
2021
Q4
$525K Buy
3,351
+92
+3% +$16.2K 0.13% 168
2021
Q3
$533K Buy
3,259
+2,228
+216% +$282K 0.13% 178
2021
Q2
$118K Sell
1,031
-186
-15% -$19.7K 0.03% 520
2021
Q1
$123K Buy
1,217
+232
+24% +$18.8K 0.04% 387
2020
Q4
$65.4K Buy
985
+390
+66% +$21.1K 0.02% 437
2020
Q3
$23.6K Buy
+595
New +$22.4K 0.01% 426
2016
Q3
Sell
-667
Closed -$22.1K 639
2016
Q2
$22.1K Buy
+667
New +$19.2K ﹤0.01% 323
2015
Q3
Sell
-4,098
Closed -$223K 554
2015
Q2
$223K Buy
4,098
+2,767
+208% +$171K 0.02% 205
2015
Q1
$86.6K Buy
+1,331
New +$88.9K 0.01% 278

Other funds holding HRI

Exane Derivatives's HRI Position: Q2 2022 in Review

Exane Derivatives reduced its Herc Holdings (HRI) stake by 40% in Q2 2022, selling an estimated $97.3K and leaving 1,197 shares worth $108K. The position accounts for 0.06% of the portfolio, ranked #256.

Exane Derivatives first reported a position in HRI in Q1 2015 and has held it in 11 quarters since. The position peaked at $533K in Q3 2021. 244 funds tracked by Wall St. Rank hold HRI as of Q2 2022.

  • Exane Derivatives held 1,197 shares of Herc Holdings worth $108K as of Q2 2022.
  • Exane Derivatives sold 810 Herc Holdings shares in Q2 2022, an estimated $97.3K.
  • Herc Holdings made up 0.06% of Exane Derivatives's portfolio in Q2 2022, its #256 holding.
  • Exane Derivatives first reported a position in Herc Holdings in Q1 2015 and has held it in 11 quarters since.
  • Exane Derivatives's Herc Holdings position peaked at $533K in Q3 2021.
  • 244 funds tracked by Wall St. Rank held Herc Holdings as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.